BacTech Mining Corporation
TSX VENTURE : BM

BacTech Mining Corporation

September 05, 2007 11:28 ET

BacTech Provides Update

TORONTO, ONTARIO--(Marketwire - Sept. 5, 2007) - BacTech Mining Corporation ("BacTech" or the "Company") (TSX VENTURE:BM) advised that trading in its common shares was halted at the opening of trading on Tuesday, September 4, 2007, at the request of the Company. BacTech is in negotiations for a business combination with another group and trading will resume when the appropriate regulatory approvals have been received from the TSX Venture Exchange.

An announcement outlining the proposed transaction will be made as soon as possible.

BACTECH PROFILE

BacTech has developed and patented bacterial oxidation technology for the treatment of refractory ores and concentrates to enhance the recovery of gold, silver and base metals. BacTech has successfully commissioned three bioleach plants for gold and demonstrated its technology in the selective recovery of base metals from complex sulphide concentrates in a joint project with Industrias Penoles de C.V. of Mexico that was completed in 2001. The Company's focus is the acquisition of equity positions in projects amenable to bioleaching. Recently, the Company expanded its focus through the establishment of a uranium Joint Venture with Quinto Mining Corporation in Quebec.

Shares outstanding 57,457,205

The TSX Venture Exchange has not reviewed and does not accept any responsibility for the adequacy or accuracy of this release

Contact Information